Table 1. The rate of oxidative phosphorylation in IFM from young and aged mice with or without metformin treatment.
Mice | 3 mo. | 24 mo. | ||
Groups | Vehicle (n=13) | Metformin (n=5) | Vehicle (n=11) | Metformin (n=5) |
Complex I substrates: glutamate + malate | ||||
State 3 (nAO/min/mg) | 356±13 | 367±14 | 271±13* | 337±22† |
State 4 (nAO/min/mg) | 58±3 | 58±5 | 48±1* | 58±3† |
RCR | 6.3±0.2 | 6.6±0.5 | 5.7±0.2 | 5.9±0.5 |
2 mM ADP (nAO/min/mg) | 481±17 | 487±29 | 318±19* | 397±32† |
Complex II substrates: Succinate + rotenone | ||||
State 3 (nAO/min/mg) | 860±30 | 735±13* | 779±34 | 847±30 |
State 4 (nAO/min/mg) | 256±12 | 226±11 | 212±8* | 218±8 |
RCR | 3.4±0.1 | 3.3±0.1 | 3.7±0.1 | 3.9±0.1 |
2 mM ADP (nAO/min/mg) | 849±29 | 746±19* | 769±34 | 788±32 |
Mean ± SEM. *p<0.05 vs. 3 mo. Vehicle, †p<0.05 vs. 24 mo. Vehicle.